Webpackaging logo

Pharma-Tac Plus Label from Schreiner MediPharm wins first place in North American Tag and Label Manufacturers Institute International Competition

  • Schreiner MediPharm
Europe, Germany, Austria, Germany, Health, Pharmaceuticals, Secondary Packaging, Labels, Tags, Labelling, Sleeving, Label, Sleeve Design, Shows, Associations, Media, Packaging Awards

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has been recognized with a first place award for its Pharma-Tac Plus hanging label. Developed jointly with Octapharma, the Pharma-Tac Plus label, with an especially robust hanger for infusion bottles, was recognized in the 'multi-process' category by the North American Tag and Label Manufacturers Institute (TLMI).

The award-winning Pharma-Tac Plus label convinced the panel of expert judges with its high-level printing technology and sophisticated label design. The label for infusion bottles combines product marking with a hanger, several pages for product information, and detachable documentation parts. The tear strength and stability of the label-integrated hanger ensure secure hanging of the infusion bottle, and its two-layered construction affords ample space for product information text in three languages, necessary for meeting regulatory requirements in multilingual countries. The label can be easily opened and reclosed, and its two detachable documentation parts for patient medical records can be post-printed with the batch number.

Many of Schreiner MediPharm's other innovative products have received awards from the North American Tag and Label Manufacturers Institute, which has been sponsoring this prestigious annual international competition to recognize the industry's best products since 1977. The panel of expert judges attaches particular importance to innovation and outstanding printing and manufacturing quality.

"The Pharma-Tac Plus label provides exceptional benefits", said Gene Dul, President of Schreiner MediPharm U.S. "The label adds value to the product and is easy to integrate into existing manufacturing processes, it lends itself to efficient and reliable use by healthcare staff, and traceability of the infusion makes an important contribution to patient safety."

See also

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.

  • Company News
  • English
  • Modified 17 Oct 2016
  • Hits 845